LIFE SCIENCES EXECUTION ON SALESFORCE - One platform for your portfolio - built for the future

For years, life sciences has rented its infrastructure: a CTMS from one vendor, an EDC from another, eConsent from a third — fragmented point systems stitched together study by study. You pay in perpetuity, your data scatters across vendors, and you own none of it.

Salesforce changes the math. One platform, across your entire portfolio — every study, site, and function — that you own and control, that consolidates the tools you rent today, and that compounds in value as you build on it. Migrating to Salesforce is not a software swap. It is a decision to invest in your own infrastructure instead of someone else’s.

ClinicAL™ makes that move safe: off REDCap, third-party CTMS and EDCs, and aging orgs, onto a modern, agent-ready foundation — without losing the data integrity a regulated portfolio demands.

  Salesforce has redrawn its platform around agents. With Headless 360, every capability is an API or an agent action; Agentforce Life Sciences is the AI-native evolution of Life Sciences Cloud; Data 360 is the unified data foundation beneath it. 

Salesforce’s own direction is blunt — agents do the work, people supervise.

In most industries, that is an efficiency story. In clinical research, it is a governance question. 

An Agentforce agent working across your portfolio — drafting a consent record, flagging a deviation, moving a subject through a visit — is touching regulated, patient-facing decisions at scale. The upside is enormous: faster studies, lower cost across the portfolio, sites treated as partners rather than data-entry clerks. The risk is real when no qualified human owns the consequential call.

That is the gap ClinicAL™ fills. We are fluent in where Salesforce is going, and we bring the clinical operations judgment to get there safely.

  Clinical Ops in the Loop is our method for agentic AI in regulated research. Agents operate the workflow; the right qualified human owns every consequential decision — a scientist, biostatistician, or QA reviewer; a CRO overseeing sites; the investigator or coordinator at the site. It is how you capture the speed of Agentforce across a whole portfolio without surrendering the accountability an inspection demands.

  We don’t get paid to talk. We get paid to produce. 

Because we have run studies, we don’t need endless discovery workshops to find where the friction lives — we already know. We come in senior, map the strategy to where Salesforce is heading, and build at high quality with a scope you can plan around.

  We architect for where you are going, not just where you are — which is why we chose our partners deliberately. Salesforce, because its headless, Agentforce direction is where clinical technology is heading. Claude, a preferred model for regulated life sciences that runs inside the Salesforce trust boundary, because the AI you build on should be safe enough for patient data. 

As a Salesforce partner and a member of the Claude Partner Network, we keep your platform close to the frontier — so the investment you make today compounds instead of aging out.

  We build on Salesforce Headless 360 and integrate the modern data stack around it — Snowflake, AWS, MCP, and open APIs. Salesforce-first, not Salesforce-only, so your platform fits the architecture you already have.

  A client on a mission to cure its disease had outgrown the tools its work depended on. We built the clinical research infrastructure that mission demands on Salesforce. 

We didn’t just implement software — we built a platform to support a cure.

 Whether you are a sponsor, CRO, SMO, or site — consolidating a portfolio onto Salesforce, migrating off third-party systems, activating Agentforce, or deciding where agents genuinely belong across your studies — ClinicAL™ brings the strategy and the clinical judgment to do it right.